A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion.

Autor: Sharma, Shashikant¹ (AUTHOR) shashikant_sharma@intaspharma.com, RE-ENACT 2 Study Investigators Group (AUTHOR), Anandkumar, Manjunath Bhaskar¹ (AUTHOR), Jain, Sangita¹ (AUTHOR), Murthy, Hemanth¹ (AUTHOR), Murlidhar, Naveenam Srinivasa¹ (AUTHOR), Hirawat, Raj Shri¹ (AUTHOR), Sudhalkar, Aditya¹ (AUTHOR), Deka, Amarendra¹ (AUTHOR), Banker, Alay¹ (AUTHOR), Parikh, Vatsal¹ (AUTHOR), Agarwal, Manisha¹ (AUTHOR), Mithal, Charu¹ (AUTHOR), Singh, Rajender Pal¹ (AUTHOR), Kulkarni, Deepti¹ (AUTHOR), Desai, Abhishek¹ (AUTHOR), Naigaonkar, Rushikesh¹ (AUTHOR), Borse, Nishikant¹ (AUTHOR), Saikia, Simanta Pradeep¹ (AUTHOR), Sahu, Atul Kumar¹ (AUTHOR)

Publikováno v: Ophthalmology & Therapy. Sep2020, Vol. 9 Issue 3, p625-639. 15p.